Skip to content

assessment of serum GDNF level before/after treatment with HD- tDCS in bipolar affective disorder

SERUM GDNF AS A PREDICTOR OF RESPONSE TO HD -TDCS IN BIPOLAR AFFECTIVE DISORDER

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/018949
Enrollment
40
Registered
2019-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F31- Bipolar disorder Health Condition 2: F313- Bipolar disorder, current episodedepressed, mild or moderate severity

Interventions

Intervention1: HD tdcs: The Starstim 32 is a wearable device that wirelessly transmits the 32-channel data via wifi. Its hybrid electrodes can be used for electrical stimulation (tDCS). It Synchronize
0-500 Hz (tRNS) where Data transmission will be wireless (wi-fi network) or wired (USB cable). Control Intervention1: not applicable: not applicable

Sponsors

CENTRAL INSTITUTE OF PSYCHIATRY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of bipolar affective disorder according to diagnostic criteria of research of ICD 10 Bipolar affective disorder current episode manic with or without psychotic symptoms Age group between 18 to 45 yrs of age of either sex Patients who is drug free or drug naive for a minimum of 8 weeks Patients giving written informed consent YMRS score of more than greatyer and equal to 10

Exclusion criteria

Exclusion criteria: Presence of comorbid neurological or other psychiatric disorder History of epilepsy sustained brain damage or any neurological procedures Subjects who have received ECT or rTMS in past 2 months Developmental delay or mental retardation

Design outcomes

Primary

MeasureTime frame
Primary outcome of the study is change in GDNF levels in patients with Bipolar Affective Disorder with improvement in mood states.Timepoint: At baseline ,before application of HDtdcs and after application of HDtdcs

Secondary

MeasureTime frame
Secondary outcomes are changes in Psychopathology scores as measured by YMRS after application of HD-tDCS.Timepoint: At baseline, before application of HDtdcs and after application of HDtdcs

Countries

India

Contacts

Public ContactDr Nishant Goyal

Central Institute of psychiatry

psynishant@gmail.com9341171162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026